Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Matthew H. Kulke

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8556-3977; OpenAlex author ID A5017947396. Sources: ClinicalTrials.gov.

Their work

Papers
9
Trials
4 (principal investigator on 3)
Grants
0
Labs led
0
Collaborators
40
Papers, trials and grants by year

2001: 1 trial · 2002: none · 2003: 1 trial · 2004: 1 trial · 2005: none · 2006: none · 2007: none · 2008: none · 2009: none · 2010: 1 trial · 2011: none · 2012: none · 2013: none · 2014: 1 paper · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 4 papers · 2019: 1 paper · 2020: 1 paper

Papers 9

  1. Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1055-9965.epi-19-1315↗
  2. Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer. Co-author DOI 10.1158/1055-9965.epi-19-0370↗
  3. Plasma inflammatory cytokines and survival of pancreatic cancer patients. Co-author DOI 10.1038/s41424-018-0008-5↗
  4. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/s41467-018-02942-5↗
  5. Altered exocrine function can drive adipose wasting in early pancreatic cancer. Co-author DOI 10.1038/s41586-018-0235-7↗
  6. Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. Co-author DOI 10.1158/2159-8290.cd-18-0275↗
  7. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  8. Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus. Co-author DOI 10.1200/jco.2014.57.5688↗
  9. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗

Trials 4

  1. AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors Principal investigator NCT01024387↗
  2. Docetaxel in Combination With Iressa in Previously Treated Patients With Pancreatic Cancer Principal investigator NCT00137761↗
  3. Tarceva and Capecitabine for Pancreatic Cancer Principal investigator NCT00125021↗
  4. Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas Study chair NCT00012220↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brian Matthew Wolpin · 5 shared papers, 2015–2020 · strength 0.31
  2. Ana Babić · 4 shared papers, 2018–2020 · strength 0.27
  3. Kimmie Ng · 4 shared papers, 2015–2020 · strength 0.25
  4. Chen Yuan · 4 shared papers, 2015–2020 · strength 0.24
  5. Vicente Morales‐Oyarvide · 3 shared papers, 2018–2020 · strength 0.21
  6. Douglas Adam Rubinson · 3 shared papers, 2015–2020 · strength 0.18
  7. Charles S. Fuchs · 3 shared papers, 2015–2020 · strength 0.18
  8. Richard Francis Dunne · 2 shared papers, 2019–2020 · strength 0.15
  9. Albert C. Koong · 2 shared papers, 2018–2020 · strength 0.13
  10. Michael Hayden Rosenthal · 2 shared papers, 2018–2019 · strength 0.12
  11. Motokazu Sugimoto · 2 shared papers, 2018–2019 · strength 0.12
  12. Naoki Takahashi · 2 shared papers, 2018–2019 · strength 0.12
  13. Laura V. Danai · 2 shared papers, 2018–2019 · strength 0.12
  14. Matthew G. Vander Heiden · 2 shared papers, 2018–2019 · strength 0.12
  15. Gloria M. Petersen · 2 shared papers, 2018–2019 · strength 0.12
  16. Thomas E. Clancy · 2 shared papers, 2015–2020 · strength 0.12
  17. Tsuyoshi Hamada · 1 shared paper, 2020 · strength 0.08
  18. Yohei Masugi · 1 shared paper, 2020 · strength 0.08
  19. Margaret M. Kozak · 1 shared paper, 2020 · strength 0.08
  20. Andressa Dias Costa · 1 shared paper, 2020 · strength 0.08
  21. Chunxia Du · 1 shared paper, 2020 · strength 0.08
  22. Daniel Tandel Chang · 1 shared paper, 2020 · strength 0.08
  23. Aram F. Hezel · 1 shared paper, 2020 · strength 0.08
  24. Andrew J. Aguirre · 1 shared paper, 2020 · strength 0.08
  25. Jonathan Andrew Nowak · 1 shared paper, 2020 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.